Cinematic rendering of 18F-DCFPyL PET/CT fusion data in a patient with metastatic clear cell renal cell carcinoma
- PMID: 38873347
- PMCID: PMC11168768
- DOI: 10.1002/bco2.324
Cinematic rendering of 18F-DCFPyL PET/CT fusion data in a patient with metastatic clear cell renal cell carcinoma
Erratum in
-
Erratum.BJUI Compass. 2024 Dec 30;5(12):1324-1329. doi: 10.1002/bco2.482. eCollection 2024 Dec. BJUI Compass. 2024. PMID: 39744071 Free PMC article.
Keywords: PSMA; positron emission tomography; prostate‐specific membrane antigen.
Conflict of interest statement
EKF receives research support from Siemens and GE Healthcare and is a co‐founder and stockholder in HipGraphics, Inc. SPR and MAG have received research funding from Progenics Pharmaceuticals, Inc., a wholly owned subsidiary of Lantheus Pharmaceuticals, Inc., the licensee of 18F‐DCFPyL. SPR serves as a consultant to Progenics Pharmaceuticals, Inc. MAG has served as a consultant to Progenics Pharmaceuticals, Inc. SK is an employee of Siemens Healthineers.
Figures

References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous